Because the main side effects are different for each class (diarrhea for orlistat 9 , nausea, vomiting and constipation for GLP-1 and dual GLP-1/GIP receptor agonists 10 , and so on), a formal meta-analysis comparing non-serious adverse events could not be performed
Lampe JW, Bigler J, Bush AC, Potter JD
doi: 10.18632/oncotarget.11168
There were 10 eligible studies including 22 trials (some studies were pooled analyses including unpublished pharmaceutical data where the original study could not be located) with 9,641 patients, comparing an SGLT-2 inhibitor with placebo
Co pokazano w badaniach u ludzi: W badaniu z podwjnie lep prb, placebo i schematem crossover u 10 mczyzn z psychogennymi zaburzeniami erekcji u 8 na 10 po MT-II wystpiy klinicznie widoczne erekcje